A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc.
University Hospital Rijeka
Peter MacCallum Cancer Centre, Australia
OncoResponse, Inc.
Maastricht University Medical Center
Provectus Pharmaceuticals
Philogen S.p.A.
Herlev Hospital
Institut d'Investigació Biomèdica de Bellvitge
SpeciCare
Shanghai Junshi Bioscience Co., Ltd.
University Hospital Tuebingen
Comprehensive Cancer Centers of Nevada
AVAX Technologies
South Eastern Health and Social Care Trust
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
University of Wuerzburg
Introgen Therapeutics
Ludwig-Maximilians - University of Munich
Dermatologic Cooperative Oncology Group